Aileen Brooks v. It Works Marketing, Inc.

District Court, E.D. California·Decided June 21, 2022·No. 1:21-cv-01341·Unknown

Opinion

1 2 3 4 5 6 7 8 UNITED STATES DISTRICT COURT 9 FOR THE EASTERN DISTRICT OF CALIFORNIA 10 11 AILEEN BROOKS, on behalf of herself No. 1:21-cv-01341-DAD-BAK and all others similarly situated, 12 Plaintiff, 13 ORDER DENYING PLAINTIFF’S MOTION v. FOR A PRELIMINARY INJUNCTION AND 14 PROVISIONAL CLASS CERTIFICATION IT WORKS MARKETING, INC., et al., 15 (Doc. No. 22) Defendants. 16

17 18 This matter is before the court on a motion for a preliminary injunction and provisional 19 class certification filed on behalf of plaintiff Aileen Brooks. (Doc. No. 22.) Pursuant to General 20 Order No. 617 addressing the public health emergency posed by the COVID-19 pandemic, the 21 pending motion was taken under submission on the papers. (Doc. No. 23.) For the reasons 22 explained below, the court will deny plaintiff’s motion for a preliminary injunction and 23 provisional class certification. 24 BACKGROUND 25 A. Factual Background 26 This putative class action arises from plaintiff Aileen Brooks’ purchase of a weight loss 27 product called Thermofight Xx (“Thermofight”) from defendants It Works Marketing, Inc. and It 28 Works! Global Inc. (together, “It Works!”). 1 Plaintiff, a Bakersfield resident, proceeds on her first amended class action complaint 2 (“FAC”) against defendants It Works! and defendants Mark Pentecost, the It Works! founder and 3 CEO, and Paul Nassif, a plastic surgeon and reality TV star who has developed and promoted 4 products for It Works!. (Doc. No. 17.) In her FAC, plaintiff alleges that she purchased 5 Thermofight from an independent distributor in reliance on defendants’ representations that it was 6 a safe and effective weight control product. (Id. at ¶¶ 77–78.) Despite alleging that she used 7 Thermofight as directed, plaintiff claims it did not deliver on its advertised benefits or provide 8 any results at all. (Id. at ¶¶ 79–81.) Moreover, plaintiff alleges that when making her initial 9 purchase she was enrolled in an auto-shipment program without her knowledge, which required a 10 minimum of three purchases of Thermofight (one per month). (Id. at ¶¶ 200–02.) Plaintiff 11 alleges that she was charged for two purchases of Thermofight before realizing that she had been 12 enrolled in the auto-shipment program. (Id. at ¶ 204.) Although plaintiff was able to cancel 13 future shipments over the phone, her request for a refund for the second shipment was denied. 14 (Id. at ¶¶ 204–05.) Plaintiff alleges that these auto-billing practices constitute an unlawful 15 “automatic renewal” prohibited under California law. (Id. at ¶ 206.) Plaintiff does not allege that 16 she suffered any other injuries from using Thermofight. 17 Aside from her individual allegations, plaintiff is also suing on behalf of two putative 18 classes and the general public. (Id. at ¶¶ 265–67, 297, 306, 310, 315.) As detailed in her FAC, 19 plaintiff alleges that defendants, collectively, have defrauded the public by marketing, 20 distributing, and selling a suite of “unapproved weight control drugs”1 through “an illegal multi- 21 level marketing scam,” which uses “unlawful credit card repeat auto-billing practices.” (Id. at ¶ 22 3.) In addition, plaintiff claims that defendants’ Terms of Use contract is unlawful because it 23 contains several unconscionable provisions. (Id. at ¶¶ 219–39.) 24 ///// 25 ///// 26 1 Aside from Thermofight, the “suite of scam weight control drugs” allegedly includes, 27 Advanced Formula Fat Fighter (Fat Fighter), Slimming Gummies, and Carb Control Dual Action Complex (Carb Control). (Doc. No. 17 at ¶ 19.) Collectively, the court will refer to these four 28 products as the “weight control products.” 1 B. Procedural Background 2 After originally filing this lawsuit on September 3, 2021 (Doc. No. 1), plaintiff amended 3 her complaint two months later, on November 8, 2021 (Doc. No. 17), asserting several violations 4 of California consumer protection statutes. (Id. at ¶¶ 281–314.) Specifically, plaintiff asserts the 5 following five claims against defendants in her operative FAC: (1) violation of the California 6 Unfair Competition Law’s (UCL) unlawful prong; (2) violation of the UCL’s fraudulent prong; 7 (3) violation of the UCL’s unfair prong; (4) violation of California’s False Advertising Law 8 (FAL); and (5) violation of California’s Consumer Legal Remedies Act (CLRA). (See id.) 9 In conjunction with these five claims, plaintiff seeks injunctive relief, including an order 10 enjoining defendants from “continuing to conduct business through unlawful, unfair, and 11 fraudulent acts and practices,” engaging in “deceptive and unlawful advertising practices,” and 12 entering into contracts which allegedly contravene California law. (Id. at ¶¶ 301, 303, 307, 312.) 13 Plaintiff also prays for several equitable remedies, including restitution, disgorgement, and orders 14 enjoining defendants’ allegedly “deceptive, unconscionable, and fraudulent practices” and 15 requiring that they engage in a corrective advertising campaign. (Id. at ¶ 315.) 16 On December 21, 2021, over three and half months after initiating this lawsuit, plaintiff 17 filed the pending motion. (Doc. No. 22.) In support of that motion, plaintiff filed four 18 declarations with attached exhibits: (i) the declaration of plaintiff’s counsel, Gregory S. Weston 19 (Doc. No. 22-2); (ii) the declaration of Nathan Wong, a professor of medicine and epidemiology 20 at University of California, Irvine’s (UCI) School of Medicine and the director of UCI’s heart 21 disease prevention program (Doc. No. 22-3); (iii) the declaration of William M. London, a 22 professor of public health at California State University, Los Angeles (Doc. No. 22-4); and (iv) 23 the declaration of Robert L. FitzPatrick, a co-author of two books regarding multi-level marketing 24 (MLM) and pyramid schemes (Doc. No. 22-5). Plaintiff, however, did not include a declaration 25 of her own in support of the pending motion. 26 Defendants filed an opposition brief on January 18, 2022, arguing, among other things, 27 that plaintiff cannot show that she is in imminent danger of suffering any irreparable injury. 28 (Doc. No. 29 at 8.) Plaintiff filed her reply brief on January 25, 2022, contending that she has 1 offered sufficient evidence of injury, that she seeks “public injunctive relief,” and that she has no 2 adequate remedy at law. (Doc. No. 30 at 8–13.) In the proposed order filed with her pending 3 motion, plaintiff details the “three forms of injunctive relief” requested in her motion: (1) 4 enjoining defendants’ advertising and sale of defendants four weight control products; (2) 5 enjoining defendants’ auto-billing practices; and (3) enjoining defendants’ “use of exculpatory 6 contract provisions which she contends are unlawful and unconscionable waivers of unwaivable 7 rights.” (Doc. No. 22-6 at 2.) 8 C. Plaintiff’s Evidence of Irreparable Harm 9 In her pending motion, plaintiff contends that she, the putative classes, and “the public” 10 will suffer imminent and irreparable harm absent this court issuing preliminary injunctive relief. 11 (Doc. No. 22-1 at 22–26.) Plaintiff alleges five such harms. First, plaintiff asserts that promoting 12 “unapproved drugs” causes irreparable harm based on an FDA webpage where it generically lists 13 harms from “unapproved drugs.”2 (Id. at 23–24.) She included copies of FDA enforcement 14 letters sent to non-It Works! companies. (Doc. No. 22-2 at ¶¶ 9–12.) Second, plaintiff relies on 15 the declarations from professor of epidemiology Nathan Wong, professor of public health 16 William M. London, and author Robert L. FitzPatrick as support for additional alleged harms 17 from “unapproved drugs.” (Doc. No.

Free access — add to your briefcase to read the full text and ask questions with AI

Aileen Brooks v. It Works Marketing, Inc., (E.D. Cal. 2022).

Aileen Brooks v. It Works Marketing, Inc. (Aileen Brooks v. It Works Marketing, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Sampson v. Murray
415 U.S. 61 (Supreme Court, 1974)
Center for Food Safety v. Vilsack
636 F.3d 1166 (Ninth Circuit, 2011)
TrafficSchool.com, Inc. v. Edriver Inc.
653 F.3d 820 (Ninth Circuit, 2011)
Perfect 10, Inc. v. Google, Inc.
653 F.3d 976 (Ninth Circuit, 2011)
United States v. Joseph Everett Thomas
24 F.3d 829 (Sixth Circuit, 1994)
Stormans, Inc. v. Selecky
586 F.3d 1109 (Ninth Circuit, 2009)
Klein v. City of San Clemente
584 F.3d 1196 (Ninth Circuit, 2009)
The Lands Council v. McNair
537 F.3d 981 (Ninth Circuit, 2008)
In Re Tobacco II Cases
207 P.3d 20 (California Supreme Court, 2009)
Jacobsen v. Katzer
609 F. Supp. 2d 925 (N.D. California, 2009)
California Ass'n of Dispensing Opticians v. Pearle Vision Center, Inc.
143 Cal. App. 3d 419 (California Court of Appeal, 1983)
McGill v. Citibank, N.A.
393 P.3d 85 (California Supreme Court, 2017)
East Bay Sanctuary Covenant v. Donald Trump
993 F.3d 640 (Ninth Circuit, 2020)
Rachel Stover v. Experian Holdings, Inc.
978 F.3d 1082 (Ninth Circuit, 2020)